Clinical Trial Update: Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a vaccine plus interleukin-2 for advanced melanoma has completed. The study covered recurrent and stage IV melanoma and was sponsored b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interleukin-2 (interleukin-2)
• Vaccine (vaccine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Melanoma, Stage IV Melanoma | Phase 2 | Status: COMPLETED